Thrombotic Events
| Event . | Platelet Count (×109/L) at Time of Event . | Treatment Arm . |
|---|---|---|
| Cerebral infarction | 8 × 109/L | Placebo |
| Subclavian vein thrombosis (catheter associated) | 3,174 × 109/L | PEG-rHuMGDF to target (Gp A) |
| Thrombosis in mesenteric vein (operative specimen) | 7 × 109/L | PEG-rHuMGDF to target (Gp A) |
| Brachiocephalic/subclavian vein thrombosis (catheter associated) | 546 × 109/L | Placebo |
| Event . | Platelet Count (×109/L) at Time of Event . | Treatment Arm . |
|---|---|---|
| Cerebral infarction | 8 × 109/L | Placebo |
| Subclavian vein thrombosis (catheter associated) | 3,174 × 109/L | PEG-rHuMGDF to target (Gp A) |
| Thrombosis in mesenteric vein (operative specimen) | 7 × 109/L | PEG-rHuMGDF to target (Gp A) |
| Brachiocephalic/subclavian vein thrombosis (catheter associated) | 546 × 109/L | Placebo |